Literature DB >> 29266273

Cerebrovascular and Alzheimer disease: fellow travelers or partners in crime?

Antonia Nucera1, Vladimir Hachinski1,2.   

Abstract

In this review, we will discuss the progressive decline in cognitive and intellectual performance in late life that has led to great challenges for medical and community services. The term 'vascular cognitive impairment' is defined as any cognitive impairment that is caused by or associated with vascular factors. It can occur alone or in association with Alzheimer disease. The good news is that because vascular risk factors are treatable, it should be possible to prevent or delay some dementias. Since vascular cognitive impairment may often go unrecognized, many experts recommend screening with brief tests to assess memory, thinking, and reasoning for everyone considered to be at high risk for this disorder. Up to 64% of persons 65 years or older who have experienced a stroke have some degree of cognitive impairment with up to one third developing dementia. Postmortem studies indicate that up to 34% of dementia cases show significant vascular pathology. It suggests that ischemic stroke triggers additional pathophysiological process that may lead to a secondary degenerative process that may interact with Alzheimer disease pathology thus accelerating the ongoing primary neurodegeneration. Mechanisms could include hypoperfusion, hypoxia, and neuroinflammation, one of the links between the two pathologies. Stroke and dementia share the same risk and protective factors. Since stroke interact with dementia of all types it may already be possible to reduce or delay some dementias by a number of interventions known to prevent stroke. This article is part of the Special Issue "Vascular Dementia".
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer disease; cerebrovascular; transient ischemic attack

Mesh:

Year:  2018        PMID: 29266273     DOI: 10.1111/jnc.14283

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Mild Cognitive Impairment that Does Not Progress to Dementia: A Population-Based Study.

Authors:  Mary Ganguli; Yichen Jia; Tiffany F Hughes; Beth E Snitz; Chung-Chou H Chang; Sarah B Berman; Kevin J Sullivan; M Ilyas Kamboh
Journal:  J Am Geriatr Soc       Date:  2018-11-16       Impact factor: 5.562

Review 2.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

3.  Intracellular Neuroprotective Mechanisms in Neuron-Glial Networks Mediated by Glial Cell Line-Derived Neurotrophic Factor.

Authors:  Еlena V Mitroshina; Tatiana A Mishchenko; Olesya M Shirokova; Tatiana A Astrakhanova; Maria M Loginova; Ekaterina A Epifanova; Alexey A Babaev; Victor S Tarabykin; Maria V Vedunova
Journal:  Oxid Med Cell Longev       Date:  2019-11-18       Impact factor: 6.543

4.  Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

Authors:  Victor Teatini Ribeiro; Thiago Macedo E Cordeiro; Roberta da Silva Filha; Lucas Giandoni Perez; Paulo Caramelli; Antônio Lúcio Teixeira; Leonardo Cruz de Souza; Ana Cristina Simões E Silva
Journal:  Front Neurosci       Date:  2021-04-06       Impact factor: 4.677

Review 5.  Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer's Disease.

Authors:  Karl Herholz
Journal:  Brain Sci       Date:  2022-01-23

6.  The Dose-Dependent Effects of Vascular Risk Factors on Dynamic Compensatory Neural Processes in Mild Cognitive Impairment.

Authors:  Haifeng Chen; Fan Su; Qing Ye; Zan Wang; Hao Shu; Feng Bai
Journal:  Front Aging Neurosci       Date:  2018-05-08       Impact factor: 5.750

7.  AAV-Syn-BDNF-EGFP Virus Construct Exerts Neuroprotective Action on the Hippocampal Neural Network during Hypoxia In Vitro.

Authors:  Еlena V Mitroshina; Tatiana A Mishchenko; Alexandra V Usenko; Ekaterina A Epifanova; Roman S Yarkov; Maria S Gavrish; Alexey A Babaev; Maria V Vedunova
Journal:  Int J Mol Sci       Date:  2018-08-05       Impact factor: 5.923

8.  Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer's Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer's Disease.

Authors:  Macrina Tortajada-Soler; Leticia Sánchez-Valdeón; Marta Blanco-Nistal; José Alberto Benítez-Andrades; Cristina Liébana-Presa; Enrique Bayón-Darkistade
Journal:  Int J Environ Res Public Health       Date:  2020-05-13       Impact factor: 3.390

Review 9.  Adiponectin and Cognitive Decline.

Authors:  Maria Rosaria Rizzo; Renata Fasano; Giuseppe Paolisso
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

10.  Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology.

Authors:  RuiJuan Chen; Yi Shu; Yi Zeng
Journal:  Front Aging Neurosci       Date:  2020-01-08       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.